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Introduction
Ambulatory blood pressure monitoring (ABPM)
has allowed the presence of a diurnal rhythm of blood
pressure (BP) and heart rate (HR) to be demon-
strated [1]. It has been established that the circadian
pattern of BP and HR is characterised by low values
during sleep and higher values during wakefulness.
Data based on 24-hour ABPM have demonstrated that
the nocturnal decline of BP may be diminished or even
Streszczenie
Wstęp Brak nocnego obniżenia ciśnienia tętniczego prowa-
dzi do zwiększonej częstości powikłań narządowych nadciś-
nienia tętniczego, a jego przyczyny pozostają niejasne. Celem
pracy była ocena zależności między biochemicznymi wykład-
nikami aktywności współczulnej a rytmem dobowym ciśnie-
nia u chorych z pierwotnym nadciśnieniem tętniczym.
Materiał i metody Do badania zakwalifikowano 68 chorych
z nadciśnieniem tętniczym w średnim wieku 40 ± 1 lat
(20 K, 48 M). Do grupy kontrolnej włączono 25 zdrowych
ochotników w średnim wieku 38 ± 1 lat (8 K i 17 M).
U badanych wykonywano 24-godzinny pomiar ciśnienia
(SpaceLabs 90207) oraz oznaczano we krwi stężenie kate-
cholamin i neuropeptydu Y. Całodobowo prowadzono
zbiórkę moczu w celu oznaczenia wydalania katecholamin.
Wyniki U chorych z nadciśnieniem tętniczym stężenie
neuropeptydu Y było wyższe niż u osób zdrowych. Stęże-
nie katecholamin w surowicy i ich wydalanie z moczem
były w obu grupach podobne. Chorych z nadciśnieniem
podzielono na dwie grupy zależnie od obecności — dip-
pers (46 chorych) — lub braku nocnego obniżenia ciśnie-
nia — non-dippers (22 chorych). Stężenie neuropeptydu Y
było istotnie wyższe w grupie non-dippers niż w grupie
dippers (10,6 ± 1 vs. 8,6 ± 1 fmol/ml, p < 0,05). Nie
stwierdzono między grupami różnic w zakresie stężenia
katecholamin w surowicy i katecholamin wydalanych
z moczem. W obu grupach wydalanie katecholamin w cza-
sie nocy było istotnie niższe aniżeli w ciągu dnia. Nocne
i dzienne wydalanie katecholamin było podobne w grupie
dippers i non-dippers.
Wnioski Uzyskane wyniki wskazują, że neuropeptyd Y
może wpływać na zaburzenie rytmu dobowego ciśnienia
tętniczego u chorych z nadciśnieniem i brakiem nocnego
obniżenia ciśnienia. Prawdopodobnie katecholaminy nie
wpływają na dobowy rytm ciśnienia tętniczego.
słowa kluczowe: neuropeptyd Y, katecholaminy,
24-godzinny ambulatoryjny pomiar ciśnienia tętniczego,
dippers, non-dippers
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absent in some subjects called non-dippers [2, 3]. In
contrast, patients with preserved circadian rhythm are
described as dippers. Non-dippers have come to be
arbitrarily identified as patients whose nocturnal re-
duction in BP is more than 10% of the diurnal BP
values. ABPM has shown that repeated BP recordings
better represent the mean blood pressure of an indi-
vidual subject and better correlate with several indices
of hypertension-related end-organ damage than office
blood pressure [4]. Non-dippers were characterised as
associated with increased frequency of end-organ dam-
age and poorer prognosis for cardiovascular events, as
compared to dippers [4]. The reasons why BP and HR
have a circadian rhythm with nocturnal blood pressure
decline remain unclear. Some data indicate that circa-
dian rhythm is influenced by extrinsic factors like the
mental and physical activity of investigated subjects
[5]. Other data point to intrinsic, i.e. physiological and
pathophysiological, factors [6]. While most evidence
favours the theory of extrinsic factors, clinical studies
show that some hormonal disorders, like hyperaldos-
teronism or excessive production of glucocorticoids,
can lead to blunting or absence of nocturnal fall in
blood pressure [7, 8]. Also some data point to a rela-
tionship between the circadian rhythm of BP and the
sympathetic nervous system activity.
The present study was designed to determine the
relationship between hormonal indices of the sym-
pathetic activity (catecholamines, neuropeptide Y)
and disturbances in diurnal blood pressure rhythm
in hypertensive patients.
Material and methods
The study group consisted of 68 patients (20
women, 48 men), mean age 40 ± 1 years. All patients
had newly diagnosed mild to moderate hypertension
or they had not received any antihypertensive medica-
tion for at least 14 days before the study. Ambulatory
blood pressure was higher than: systolic 134 mm Hg
and/or diastolic 90 mm Hg in all hypertensives. Be-
fore the study secondary forms of hypertension were
excluded in all investigated subjects. The control
group consisted of 28 healthy normotensive volun-
teers (8 women, 20 men), mean age 38 ± 1 years.
ABPM was performed using a SpaceLabs 90207 de-
vice (SpaceLabs Inc. Redmond, Washington, USA).
The device was programmed to measure BP every 15
minutes during the daytime (6.00 AM to 10.00 PM)
and every 20 minutes during the night (10.00 PM to
6.00 AM). Urine collections for norepinephrine (NE),
epinephrine (E) and dopamine (D) were performed
separately between 6.00 AM and 10.00 PM and then
from 10.00 PM to 6.00 AM. Urine NE and E were
measured by the fluorometric method. A venous blood
sample was taken at 08.00 AM after participants had
been resting in a supine position for 30 minutes. Blood
samples were collected into ice-cold tubes containing
sodium EDTA (1 mg/ml) and aprotinin (500 U/ml)
for NPY, and EDTA glutatione for catecholamines.
All samples were immediately centrifuged at +4oC,
2000 g for 30 min and aliquots of plasma were frozen
at –20oC until assayed. Plasma NPY concentration
was determined by radioimmunoassay using Penin-
sula antibodies (RAS 7172), standard (7172) and
Amersham iodinated NPY (IM 170). The intra- and
interassay coefficients of variation were 8% and 14%,
respectively. The catecholamine plasma concentration
was determined by the radioenzymatic method using
a commercial kit (Upjohn). The intra-assay coeffi-
cient of variation was 3,1% for E and 4,2% for NE.
The interassay coefficient of variation was 6,6% for E
and 7,4% for NE.
The protocol of the study was reviewed and ap-
proved by the Ethical Committee of the Medical Acad-
emy. All study parameters are expressed as a mean
value followed by standard error (mean ± SE). Statis-
tical analysis was performed using Student’s t-test and
the Mann-Whitney test. Differences with a value of
p < 0,05 were considered to be significant.
Results
We investigated 68 hypertensives (20 females,
48 males) and 25 normotensive (8 females, 17 males)
volunteers. Subjects did not differ from healthy pa-
tients with regard to age (40 ± 1 vs. 38 ± 1 yrs) and
body mass index — BMI (28 ± 3 vs. 26 ± 3 kg/m2,
respectively). There were significant differences in of-
fice systolic (159 ± 2 vs. 121 ± 2 mm Hg, p < 0,01)
and diastolic (104 ± 1 vs. 78 ± 2 mm Hg, p < 0,01)
BP, while no differences were found in HR (72 ± 1 vs.
64 ± 2 beats/min) between the groups. In accordance
with 10% diurnal — nocturnal difference as a cut-off
point, hypertensive patients (68) were divided into two
groups: dippers (D — 46) and non-dippers (ND
— 22). No differences in age (40 ± 1 vs. 40 ± 1 yrs),
BMI (28 ± 3 vs. 28 ± 3 kg/m2), basal systolic BP (155 ±
± 2 vs. 161 ± 2 mm Hg), diastolic BP (102 ± 2
vs. 106 ± ± 2 mm Hg) and HR (72 ± 2 vs. 70 ± 1,
respectively) were found between dippers and
non-dippers.
Mean systolic and diastolic BP values during 24 h,
daytime and night-time were significantly higher
in hypertensive patients as compared to controls
(Table I). Heart rate during 24 h, daytime and night-
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time was similar in both groups (Table I). Dippers
and non-dippers had similar mean systolic and
diastolic BP during 24 h and daytime. Night-time
systolic and diastolic BP were significantly lower in
dippers than in non-dippers (Table I). HR during 24
h, daytime and night-time was similar in dippers and
non-dippers, but in both groups significantly lower
during the night than during the day (Table I).
Nocturnal systolic and diastolic BP fall (DSBP and
DDBP) and mean night blood pressure (MBP) fall
were similar in hypertensive patients and in control
subjects, while nocturnal HR decline (DHR) was sig-
nificantly higher in controls (Table I). Non-dippers
had a significantly lower nocturnal fall in systolic and
diastolic BP and in HR than dippers (Table I). Night
mean BP fall was significantly higher in dippers as
compared to non-dippers (Table I).
Plasma NE, E and D concentrations were similar
in hypertensives and controls (NE 359 ± 16 vs. 348 ±
± 26 pg/mL, E 86 ± 4 vs. 85 ± 6 pg/mL and D 120 ±
± 9 vs. 94 ± 10 pg/mL, respectively. Also no differ-
ences were observed between non-dippers and dip-
pers with regard to plasma catecholamine concentra-
tions (NE 369 ± 16 vs. 354 ± 20 pg/mL, E 79 ± 5 vs.
89 ± 7 pg/mL and D 109 ± 9 vs. 126 ± 10 pg/mL,
respectively). Plasma NPY concentration was signifi-
cantly higher in hypertensive patients as compared to
controls (NPY 9,2 ± 1 vs. 6.8 ± 1 fmol/mL, p < 0,05)
and in non-dippers as compared to dippers and
to controls (10,6 ± 1 vs. 8,6 ± 1 — p < 0,05 and vs.
6,8 ± 1 fmol/mL — p < 0,001) (Fig. 1).
Urine catecholamine excretion during 24 h was
similar in hypertensive patients and in controls (NE
15,7 ± 0,5 vs. 18,1 ± 1,7 ug/24 h, E 2,7 ± 0,5 vs. 3,0 ±
± 0,3 ug/24 h and D 139 ± 8 vs. 143 ± 19 ug/24 h,
respectively). There were no significant differences
between non-dippers and dippers with regard to
urine catecholamine excretion during the daytime
and night-time (Table II). Also no differences were
found between groups when hormone excretion was
recalculated as rate per one hour (non-dippers vs.
dippers NE day: 0,82 ± 0,04 vs. 0,84 ± 0,03 mg/h,
NE night 0,31 ± 0,04 vs. 0,39 ± 0,03 mg/h, E day
0,15 ± 0,02 vs. 0,15 ± 0,01 mg/h, E night 0,04 ±
± 0,01 vs. 0,04 ± 0,01 mg/h, D day 5,24 ± 0,47 vs.
6,26 ± 0,48 mg/h and D night 4,77 ± 0,38 vs. 6,16 ±
± 0,5 mg/h). Urine NE excretion per hour during
the night, but not urine E and D excretion, was sig-
nificantly lower in non-dippers than in controls (0,31 ±
± 0,04 vs. 0,61 ± 0,1 mg/h, p < 0,05). No such
difference was found between dippers and controls.
One-hour urine NE and E excretion was signifi-
cantly lower during the night-time than during the
daytime in non-dippers and dippers (Table III).
Table I. Mean systolic, diastolic blood pressure, heart rate during 24 h, day and night and
nocturnal fall in systolic and diastolic blood pressure and heart rate in investigated groups
Tabela I. Średnie ciśnienie tętnicze skurczowe (SBP), rozkurczowe (DBP) i częstotliwość
serca (HR) w ciągu 24 h, z dnia i nocy oraz nocny spadek ciśnienia skurczowego i rozkurczo-
wego oraz częstoliwość serca w badanych grupach
Hypertensives Controls Non-dippers Dippers
SBP 24 h [mm Hg] 146 ± 2*   118 ± 1      149 ± 2     144 ± 1
DBP 24 h [mm Hg]   94 ± 1* 73 ± 1 97 ± 1 94 ± 1
HR 24 h [b/min] 75 ± 2 73 ± 2 72 ± 2 76 ± 2
SBP day [mm Hg] 150 ± 2*    123 ± 1   151 ± 2     150 ± 2
DBP day [mm Hg]   99 ± 1* 76 ± 1 99 ± 1 98 ± 1
HR day [b/min] 79 ± 1 78 ± 2 75 ± 2 80 ± 2
SBP night [mm Hg] 138 ± 2*   108 ± 1   147 ± 2**     134 ± 1
DBP night [mm Hg]   88 ± 1* 64 ± 1     95 ± 1** 84 ± 1
HR night [b/min] 68 ± 1 62 ± 2       67 ± 2***         68 ± 2****
DSBP [mm Hg] 15 ± 1 14 ± 1       7 ± 1** 19 ± 1
DDBP [mm Hg] 13 ± 1 11 ± 1       6 ± 1** 17 ± 1
DHR [b/min]   11 ± 1* 16 ± 1       8 ± 1** 12 ± 1
Night MBP fall (%) 11 ± 1 13 ± 1       4 ± 1** 15 ± 1
Values are means ± SEM, *p < 0,01 — hypertensives vs. control, **p < 0,001 — non-dippers vs. dippers, ***p < 0,01 — HRn vs. HRd non-dippers,
****p < 0,001 — HRn vs. HRd dippers
DSBP, DDBP, DHR — differences between: day and night systolic, diastolic blood pressure and heart rate
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Figure 1. Plasma norepinephrine, epinephrine, dopamine and NPY concentrations in investigated groups.
*p < 0,05 — hypertensives vs. controls and non-dippers vs. dippers, **p < 0,001 — non-dippers
vs. controls
Rycina 1. Stężenie noradrenaliny, adrenaliny, dopaminy i NPY w badanych grupach.
*p < 0,05 — chorzy z nadciśnieniem vs. grupa kontrolna i chorzy non-dippers vs. chorzy dippers,
**p < 0,001 — chorzy non-dippers vs. grupa kontrolna
Table II. Urine catecholamine excretion in non-dippers, dippers and control group (mean ± SE)
Tabela II. Wydalanie katecholamin z moczem u chorych non-dippers, dippers i w grupie
kontrolnej (średnia ± SE)
Non-dippers Dippers Controls
uNEd [mg/16 h] 11,7 ± 0,7 12,6 ± 0,6 13,9 ± 1,0
uNEn [mg/8 h]     3,0 ± 0,2* 3,67 ± 0,3   4,5 ± 1,0
uEd [mg/16 h]   2,0 ± 0,2   2,4 ± 0,2   2,6 ± 0,2
uEn [mg/8 h] 0,41 ± 0,1       0,43 ± 0,05** 0,87 ± 0,2
uDd [mg/16 h] 75 ± 8 89 ± 8 109 ± 14
uDn [mg/8 h] 46 ± 4 57 ± 5 73 ± 8
uNEd — day urine norepinephrine excretion, uNEn — night urine norepinephrine excretion, uEd — day urine epinephrine excretion, uEn — night urine
norepinephrine excretion, uDd — day urine dopamine excretion, uDn — night urine dopamine excretion
*p < 0,05 — uNEn in non-dippers vs. controls, **p < 0,05 — uEn in dippers vs. controls
Table III. Day and night-time urine catecholamine excretion in non-dippers and dippers
Tabela III. Dzienne i nocne wydzielanie katecholamin z moczem u chorych non-dippers
i dippers
Group Non-dippers Dippers
Time Day Night Day Night
uNE [mg/h] 0,82 ± 0,04 0,31 ± 0,04 * 0,84 ± 0,03 0,39 ± 0,04 *
uE [mg/h] 0,15 ± 0,002 0,04 ± 0,01 * 0,15 ± 0,01 0,04 ± 0,01 *
uD [mg/h]   5,2 ± 0,47   4,7 ± 0,38 6,26 ± 0,48 6,16 ± 0,5
uNE — urine norepinephrine excretion, uE — urine epinephrine excretion, uD — urine dopamine excretion
values are means ± SEM, *p < 0,001 day vs. night in dippers and non-dippers
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Urine D excretion was similar during both periods
in hypertensives with and without nocturnal BP de-
cline (Table III). Nocturnal decline in urine NE and
E excretion was similar in non-dippers and dippers.
It was observed that night urine NE excretion was
significantly lower in non-dippers than in controls
while dippers have significantly lower night urine E
excretion as compared to controls (Table II).
Discussion
It is well known that sympathetic nervous system
plays a central role in cardiovascular regulation in
both health and disease. Many experimental and
clinical data show that sympathetic activation may
be implicated in the pathogenesis of coronary artery
disease, heart failure or cardiac arrhythmias [9–12].
Evidence for increased sympathetic drive is particu-
larly strong in hypertension. Many effective antihy-
pertensive agents were found to work by interfering
with sympathetic neurotransmission, blocking car-
diac or vascular adrenoceptors and confirming
adrenergic mechanisms in the hypertensive proc-
ess [13]. Sympathetic activity disorders were also sug-
gested as playing an important role in the regulation
of abnormal circadian BP pattern. In our study we
investigated hormonal indicators of sympathetic ac-
tivity in hypertensive subjects with normal and dis-
turbed circadian BP rhythm. Similar plasma and
urine catecholamines in both healthy and hyperten-
sive subjects were found. Data concerning plasma
and urine catecholamines in hypertensives and con-
trols are not homogeneous. Some authors revealed
higher plasma and urine norepinephrine in hyper-
tensive subjects than in healthy controls [14–17].
Higher plasma catecholamines were especially found
in young patients with borderline hypertension [15, 16].
Other data showed no differences in catechola-
mines between hypertensives and controls. The
above observations reflect the heterogeneity of sub-
jects with essential hypertension in respect to sym-
pathetic activity.
When patients were divided into dippers and non-
dippers, our data showed no differences in plasma
and urine catecholamines between the two groups.
Similar plasma catecholamines in dippers and non-
dippers were also observed by Schmieder et al. [18].
Kohara et al. [19] reported higher plasma NE in
non-dippers as compared to dippers, while plasma E
and urine catecholamines were similar in both
groups [19]. It is established that sympathetic activ-
ity is reduced during sleep. Many data showed that
plasma catecholamine concentration during night-
time was lower than during daytime. Also nocturnal
urine excretion of catecholamines was lower than
that observed during the day [20, 21]. Our data sup-
port the above observations. Urine catecholamine ex-
cretion was significantly lower during the night as
compared to day excretion in healthy subjects. Also
hypertensive dippers and non-dippers had lower
urine catecholamine excretion during the night than
during the day. When dippers and non-dippers were
compared, no differences in day and night urine
catecholamines were found between the two groups.
Lack of differences in nocturnal urine catecholamine
excretion between these groups may support the sug-
gestion that night BP elevation in non-dippers is not
a result of sympathetic enhancement. The above ob-
servations have at least one significant limitation.
Although measurements of plasma and urine
catecholamines provide useful information, this does
not reflect precisely the „overall” sympathetic activ-
ity. In addition to the level of sympathetic neural
outflow, plasma catecholamine concentration is in-
fluenced by prejunctional modulation of neurotrans-
mitter release, the clearance, metabolism and uptake
of the hormone from the circulation. Therefore new
methods, such as microneurography and heart rate
variability, were employed to investigate sympathetic
activity [22, 23]. Interestingly Hojo et al. [24] showed
lower sympathetic activity during 24 hours in non-
dippers than in dippers, however in non-dippers
sympathetic activity was not lowered during the
night as it was in dippers. Kohara et al. [19], using
spectral analysis of heart rate variability, reported
higher sympathetic activity during the night than
during the daytime in non-dippers. Other authors
reported higher sympathetic activity measured with
spectral analysis of BP and HR variability during all
phases of sleep in non-dippers as compared to dip-
pers [25]. According to presented data non-dippers
are characterised by elevated sympathetic activity
during the night. Our results did not confirm the
above observations and even showed lower urine cat-
echolamine excretion during the night in non-dip-
pers as compared to controls. These observations may
suggest the contribution of other factors than
catecholamines in circadian BP regulation.
Apart from catecholamines, neuropeptide Y is
a mediator of the sympatho-adrenomedullary system.
Many data show that NPY is a potent, long-acting
vasoconstrictor, which exerts direct action and modu-
lates the effects of other mediators, such as norepine-
phrine, serotonin or angiotensin II [26]. The contri-
bution of NPY in the pathogenesis of hypertension
was shown elsewhere [27–29]. In the present study we
found higher plasma NPY concentration in hyperten-
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Summary
Background The aim of the study was to investigate
the relationship between biochemical indices of sym-
pathetic activity and diurnal blood pressure rhythm
in patients with essential hypertension.
Material and methods The study included 68 patients
with mild-to-moderate essential hypertension (EH)
(mean age 40 ± 1 yrs; 20 F, 48 M). The control group
consisted of 25 healthy normotensive volunteers (C)
(mean age 38 ± 1 yrs; 8F, 17M). Twenty-four hour
ambulatory blood pressure monitoring was obtained
using the SpaceLabs 90207. Blood samples for NPY
and catecholamines were taken. Urine for catecho-
lamines determination was collected.
Results In patients with EH NPY, plasma concen-
tration was significantly higher as compared to C.
Plasma catecholamine and urine catecholamine ex-
cretion was similar in patients with EH and in C.
Patients with EH were divided into two groups: dip-
pers (46 pts) and non-dippers (22 pts). In EH, the
NPY plasma concentration was significantly higher
in non-dippers than in dippers (10,6 ± 1 vs. 8,6 ±
± 1 fmol/mL, respectively, p < 0,05). No differences
in plasma catecholamine and urine catecholamine
excretion were found between dippers and non-dip-
pers. Urine catecholamine excretion during night-
time was significantly lower as compared to day-time
excretion in dippers and non-dippers. No differences
between the groups were found with regard to day-
time and night-time catecholamine excretion.
Conclusion NPY may play a role in diurnal blood
pressure rhythm disturbances in non-dippers with
EH. Catecholamines appear not to influence non-
dipper phenomenon.
key words: NPY, catecholamines, 24-h ambulatory
blood pressure monitoring, dippers, non-dippers
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sive patients than in controls. Similar results were
found by other authors [27, 29]. When hypertensives
were divided into non-dippers and dippers, plasma
NPY concentration was significantly higher in the
former group. Plasma NPY was significantly higher
in non-dippers than in controls, while no such differ-
ence was found between dippers and the control
group. Simultaneously our data showed a decrease of
urine catecholamine excretion during the night in
non-dippers similar to that in dippers. Interestingly,
urine NE excretion was significantly more decreased
in non-dippers than in controls. One can speculate
that the inhibition of NE excretion may be caused
by NPY, via an activation of presynaptic NPY re-
ceptors [30]. Although we observed decreased noctur-
nal NE excretion in non-dippers, its influence on BP
and HR was not reduced. Possibly high plasma NPY
may enhance the influence of NE on night BP.
As was shown before, urine and plasma NE were
similar in non-dippers and dippers, while plasma
NPY was different in both groups. However it is well
known that co-stored NPY and NE are simultane-
ously excreted in answer to different stimuli. We did
not observe such parallel changes in NPY and NE in
our patients. This observation may be related to the
mechanism mentioned above, i.e. to the inhibition of
NE excretion by higher plasma NPY via an activa-
tion of presynaptic NPY receptor. Another explana-
tion is that NPY and NE interplay is affected by
other active hormones which may play a role in diur-
nal BP changes.
Some other confirmations of the role of NPY in
non-dipper phenomenon exist. It was previously de-
scribed that NPY is a vasoconstrictor with no influ-
ence on HR [31]. Other data revealed that NPY may
influence the presynaptic inhibition of acetylocholine
release from parasympathetic nerve endings [32, 33].
We found that non-dippers are characterised by sig-
nificant night HR decrease while their BP was not
decreased. Kohara et al. [19] showed in non-dippers
that night HR was decreased despite higher noctur-
nal sympathetic activity. One can speculate that NPY
may generate lower nocturnal parasympathetic ac-
tivity and therefore influence HR decline at normal
at even increased sympathetic activity.
In conclusion, a suggestion can be made that NPY
modulate the influence of the sympathetic nervous
system on the cardiovascular system in hypertensive
subjects with a lack of nocturnal blood pressure de-
cline. The findings of this study need to be confirmed
by circadian cycle of NPY in healthy and hyperten-
sive subjects. The lack of diurnal NPY rhythm is
a limitation of our study. However, to our knowledge
there have been no such investigations until now.
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